Outside the host they can survive for 2448 hours
The primary objective of this study was to assess the safety and tolerability of SCG101 in HCC patients who were serum HBsAg positive, hepatitis B e antigen (HBeAg) negative, had HBV-DNA levels of 210 3 IU/mL, were HLA-A*02 positive, and who had failed at least one prior line of treatment
Unfortunately, a phase II clinical trial of UBX0101 (NCT03513016) was completed in patients with osteoarthritis and the promising results observed (Table 1), in vitro and in vivo, have not been up to the expectations in treated patients, leading only to a decrease of pain, without a significant improvement of the disease 30
For researchers interested in the comparison between tirzepatide and next-generation compounds like retatrutide, which adds a third receptor (GCG), our guide to retatrutide versus semaglutide provides useful context, as does our three-way comparison of semaglutide, tirzepatide, and retatrutide
